ALKBH5 deficiency decreased PD‐L1 protein level by suppressing ZDHHC3 mRNA expression in an m6A modification manner, further enhancing the efficacy of anti‐PD‐1 therapy for GBM.40 The gene discussed is CD274; the disease is glioblastoma.